Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Minakshi Bansal"'
Autor:
Manik Ahuja, Rachel Miller-Slough, Esther Adebayo-Abikoye, Callon Williams, Andrea Haubner, McKenzie G. Dooley, Minakshi Bansal, Thiveya Sathiyaseelan, Amanda Pons, Arpana Karki, Kawther Al Ksir, Brook Samuel, Phoebe Tchoua, Trisha Schuver, Praveen Fernandopulle
Publikováno v:
Chronic Stress, Vol 8 (2024)
Objective Binge drinking and heavy alcohol use are highly prevalent among college students. During the COVID-19 pandemic, due to lockdown restrictions and other challenges, many college students were burdened with loneliness, which can contribute to
Externí odkaz:
https://doaj.org/article/cf74802dbc1c43d1bfe121a27f38d322
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 7, Iss 2, Pp 41-44 (2022)
Objective: Coronavirus disease-19 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic and is giving rise to a serious health threat globally. SARS-CoV-2 infection ranges from asymptomat
Externí odkaz:
https://doaj.org/article/6b1b154bbcb74898a3490f5b58102d1b
Publikováno v:
Advances in Medical Education and Practice
Sandeep Bansal,1 Minakshi Bansal,2 Stanley White3 1Department of Medical Education, TCU and UNTHSC School of Medicine, Fort Worth, TX, USA; 2Harris College of Nursing and Health Sciences, Texas Christian University, Fort Worth, TX, USA; 3All Saints U
Publikováno v:
Advances in Educational Research and Evaluation. 1:24-31
Publikováno v:
Journal of Pediatric Hematology/Oncology.
Publikováno v:
Pediatric Hematology Oncology Journal. 6:S8-S9
Publikováno v:
Journal of Pediatric Hematology/Oncology. 43:e1267-e1268
Publikováno v:
Journal of pediatric hematology/oncology. 43(8)
Publikováno v:
Journal of pediatric hematology/oncology. 43(8)
Outcomes of high-risk and relapsed pediatric acute leukemias continue to be suboptimal. Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative modality. However
Publikováno v:
Journal of pediatric hematology/oncology. 43(7)
Chediak-Higashi syndrome is a rare immunodeficiency disorder for which hematopoietic stem cell transplant (HSCT) is the only curative treatment option. HSCT only corrects the hematological and immunologic manifestations of the disease but neurologica